SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about disclosure

19 Jul 2022 Evaluate
Eris Lifesciences has informed that the Company has given a corporate guarantee in favour of Eris Therapeutics Limited ('ETL'), a Wholly Owned Subsidiary, for securing the term loan facility that it availed from Citi Bank N.A. Further, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para B (11) of Part A to the Schedule III of the Listing Regulations and circular issued by the Securities and Exchange Board of India vide no. CIR/CFD/CMD/4/2015 dated September 9, 2015, details attached.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1446.50 -18.90 (-1.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×